Primary Parkinsonian Pain Diagnostic Questionnaire: Development and Validation of This Questionnaire — 3PDQ  

Parkinson Disease Clinical Trial

Official title: Development and Validation of a Diagnosis Questionnaire of Primary Parkinsonian Pain: the 3 PDQ Primary Parkinsonian Pain Diagnostic Questionnaire

Status Completed

Clinical Trial Summary

Development and validation of a diagnosis questionnaire of parkinsonian primary pain: the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ)

Clinical Trial Description

The aim of this study is to develop and validate a French self-questionnaire to diagnose parkinsonian primary : the "Primary Parkinsonian Pain Diagnostic Questionnaire" (3PDQ). It will allow clinicians to distinguish this pain from the other pain of the parkinsonian patient (whether or not related to Parkinson's disease).

The development and validation of the 3PDQ self-questionnaire will take place in 3 sequential steps:

1. design of the self-questionnaire

2. appearance validity study

3. validation of the self-questionnaire

Participants :

Appearance validity study: 40 painful parkinsonian patients Validation study: 200 painful parkinsonian patients (10 patients per item)

Duration of the study :

Duration of the inclusion period:

• Appearance validity study : 6 months

• Validity study : 20 months

Duration of participation for each patient:

• Appearance validity study : about 30 min

• Validity study : 3 days maximum Total duration of the study: (with results analysis): 3 years ;

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT03940872
• Study type: Interventional
• Source: University Hospital, Toulouse
• Status: Completed
• Phase: N/A
• Start date: April 23, 2019
• Completion date: December 14, 2022